🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00509L802 (prev. 00509L703 )
- Market Cap
- Micro Cap · $36 Million
- Previous Symbol
- ACPH
Business: Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address medication abuse and misuse, utilizing its proprietary AVERSION and IMPEDE technologies. AVERSION contains polymers that cause the drug to gel when dissolved; it also contains compounds that irritate the nasal passages. IMPEDE is designed to disrupt the processing of pseudoephedrine from tablets into methamphetamine.
Notes: August 27, 2015 -- The Company announced today that it will effect a 1-for-5 reverse stock split of its common stock with a new CUSIP number of 00509L802.
Company Contact
- CEO
- Robert B. Jones
- CFO
- Peter A. Clemens
- Headquarters
- 616 N. North Court, Suite 120, Palatine, IL 60067
- Phone
- 847-705-7709
- Fax
- 847-705-5399
- Investor Relations
- Peter A. Clemens · 847-705-7709 · investors@acurapharm.com